Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1660886rdf:typepubmed:Citationlld:pubmed
pubmed-article:1660886lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C0020291lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C0031621lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C0034826lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C0443301lld:lifeskim
pubmed-article:1660886lifeskim:mentionsumls-concept:C1620102lld:lifeskim
pubmed-article:1660886pubmed:issue35lld:pubmed
pubmed-article:1660886pubmed:dateCreated1992-1-17lld:pubmed
pubmed-article:1660886pubmed:abstractTextThe relationship between muscarinic receptor activation of phosphoinositide hydrolysis and the sequestration of cell surface muscarinic receptors has been examined for both intact and digitonin-permeabilized human SK-N-SH neuroblastoma cells. Addition of the aminosteroid 1-[6-[[17 beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino] hexyl]-1H-pyrrole-2,5-dione (U-73122) to intact cells resulted in the inhibition of oxotremorine-M-stimulated inositol phosphate release and of Ca2+ signaling by greater than 75%. In contrast, when phospholipase C was directly activated by the addition of the calcium ionophore ionomycin, inclusion of U-73122 had little inhibitory effect. Addition of U-73122 to intact cells also inhibited the agonist-induced sequestration of cell surface muscarinic receptors and their subsequent down-regulation with an IC50 value (4.1 microM) similar to that observed for inhibition of inositol phosphate release (3.7 microM). In contrast, when oxotremorine-M-stimulated phosphoinositide hydrolysis was inhibited by depletion of extracellular Ca2+, no reduction in the extent of receptor sequestration was observed. When introduced into digitonin-permeabilized cells, U-73122 more markedly inhibited inositol phosphate release elicited by either oxotremorine-M or guanosine-5'-O-(3-thiotriphosphate) than that induced by added Ca2+. Addition of oxotremorine-M to permeabilized cells resulted in muscarinic receptor sequestration and down-regulation. Both the loss of muscarinic acetylcholine receptors and activation of phosphoinositide hydrolysis in permeabilized cells were inhibited by the inclusion of guanosine-5'-O-(2-thiodiphosphate). The results indicate that the agonist-induced sequestration of muscarinic acetylcholine receptor in SK-N-SH cells requires the involvement of a GTP-binding protein but not the production of phosphoinositide-derived second messenger molecules.lld:pubmed
pubmed-article:1660886pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:languageenglld:pubmed
pubmed-article:1660886pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:citationSubsetIMlld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1660886pubmed:statusMEDLINElld:pubmed
pubmed-article:1660886pubmed:monthDeclld:pubmed
pubmed-article:1660886pubmed:issn0021-9258lld:pubmed
pubmed-article:1660886pubmed:authorpubmed-author:FisherS KSKlld:pubmed
pubmed-article:1660886pubmed:authorpubmed-author:BleasdaleJ...lld:pubmed
pubmed-article:1660886pubmed:authorpubmed-author:ThompsonA KAKlld:pubmed
pubmed-article:1660886pubmed:authorpubmed-author:MostafapourS...lld:pubmed
pubmed-article:1660886pubmed:authorpubmed-author:DenlingerL...lld:pubmed
pubmed-article:1660886pubmed:issnTypePrintlld:pubmed
pubmed-article:1660886pubmed:day15lld:pubmed
pubmed-article:1660886pubmed:volume266lld:pubmed
pubmed-article:1660886pubmed:ownerNLMlld:pubmed
pubmed-article:1660886pubmed:authorsCompleteYlld:pubmed
pubmed-article:1660886pubmed:pagination23856-62lld:pubmed
pubmed-article:1660886pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:meshHeadingpubmed-meshheading:1660886-...lld:pubmed
pubmed-article:1660886pubmed:year1991lld:pubmed
pubmed-article:1660886pubmed:articleTitleThe aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation.lld:pubmed
pubmed-article:1660886pubmed:affiliationNeuroscience Laboratory, University of Michigan, Ann Arbor 48104-1687.lld:pubmed
pubmed-article:1660886pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1660886pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1660886lld:pubmed
More...